Cargando…
Advances in mass spectrometry-based clinical biomarker discovery
The greatest unmet needs in biomarker discovery are those discoveries that lead to the development of clinical diagnostic tests. These clinical diagnostic tests can provide early intervention when a patient would present otherwise healthy (e.g., cancer or cardiovascular disease) and aid clinical dec...
Autores principales: | Crutchfield, Christopher A., Thomas, Stefani N., Sokoll, Lori J., Chan, Daniel W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705754/ https://www.ncbi.nlm.nih.gov/pubmed/26751220 http://dx.doi.org/10.1186/s12014-015-9102-9 |
Ejemplares similares
-
Present and Future Applications of High Resolution Mass Spectrometry in the Clinic
por: Crutchfield, Christopher A., et al.
Publicado: (2014) -
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021) -
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
por: Wu, Jianqiang, et al.
Publicado: (2020) -
Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007) -
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
por: Zhang, Ying, et al.
Publicado: (2014)